We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-0.01%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$35.6B
AUM Growth
+$1.38B
(+4%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
5.13%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
2,407
New
40
Increased
606
Reduced
1,352
Closed
406
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$172M |
| 2 |
Honeywell
HON
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$159M |
| 4 |
Amazon
AMZN
|
+$91M |
| 5 |
Tesla
TSLA
|
+$89.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.3M |
| 2 |
STMP
Stamps.com, Inc.
STMP
|
+$42.3M |
| 3 |
Magnite
MGNI
|
+$36.1M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$34.8M |
| 5 |
Etsy
ETSY
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Consumer Discretionary | 14.43% |
| 3 | Communication Services | 10.72% |
| 4 | Healthcare | 9.96% |
| 5 | Financials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Extreme Networks
EXTR
$3.86B
| $195K | ﹤0.01% |
19,811
-16,325
| -45% | -$172K |
|
1802
PBF Energy
PBF
$7.29B
| $194K | ﹤0.01% |
14,959
-12,812
| -46% | -$133K |
|
1803
Pitney Bowes
PBI
$2.42B
| $194K | ﹤0.01% |
26,919
-23,597
| -47% | -$185K |
|
1804
Coty
COTY
$2.33B
| $193K | ﹤0.01% |
24,526
+2,210
| +10% | +$18.9K |
|
|
INFN
1805
DELISTED
Infinera Corporation Common Stock
INFN
| $193K | ﹤0.01% |
23,204
-22,961
| -50% | -$208K |
|
|
GTHX
1806
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $189K | ﹤0.01% |
14,070
-3,660
| -21% | -$59.6K |
|
1807
Rocket Companies
RKT
$36.9B
| $188K | ﹤0.01% |
11,740
+54
| +0.5% | +$944 |
|
1808
Senseonics Holdings Inc
SENS
$254M
| $188K | ﹤0.01% |
2,770
-2,618
| -49% | -$178K |
|
1809
Opko Health
OPK
$921M
| $187K | ﹤0.01% |
51,208
-171,192
| -77% | -$637K |
|
1810
Verastem
VSTM
$532M
| $187K | ﹤0.01% |
5,059
-1,242
| -20% | -$45.6K |
|
1811
Empire State Realty Trust
ESRT
$976M
| $184K | ﹤0.01% |
18,329
-18,777
| -51% | -$203K |
|
1812
Pliant Therapeutics
PLRX
$67.5M
| $182K | ﹤0.01% |
10,759
-1,933
| -15% | -$41K |
|
|
BRKL
1813
DELISTED
Brookline Bancorp
BRKL
| $181K | ﹤0.01% |
11,855
-10,191
| -46% | -$148K |
|
|
TELL
1814
DELISTED
Tellurian Inc.
TELL
| $180K | ﹤0.01% |
46,157
-36,078
| -44% | -$123K |
|
|
SUMO
1815
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $177K | ﹤0.01% |
10,994
-10,173
| -48% | -$202K |
|
|
CLVS
1816
DELISTED
Clovis Oncology, Inc.
CLVS
| $177K | ﹤0.01% |
39,752
-4,909
| -11% | -$23.6K |
|
|
AERI
1817
DELISTED
Aerie Pharmaceuticals
AERI
| $177K | ﹤0.01% |
15,517
-3,890
| -20% | -$56.9K |
|
|
KDNY
1818
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $176K | ﹤0.01% |
13,812
-2,363
| -15% | -$31.1K |
|
1819
MeiraGTx Holdings
MGTX
$1.09B
| $175K | ﹤0.01% |
13,285
-2,399
| -15% | -$32.8K |
|
1820
Theravance Biopharma
TBPH
$874M
| $173K | ﹤0.01% |
23,383
-2,177
| -9% | -$24.4K |
|
1821
Akebia Therapeutics
AKBA
$327M
| $172K | ﹤0.01% |
59,634
-10,588
| -15% | -$30.2K |
|
1822
Archrock
AROC
$6.33B
| $171K | ﹤0.01% |
20,742
-17,766
| -46% | -$143K |
|
1823
Golar LNG
GLNG
$4.95B
| $171K | ﹤0.01% |
13,177
-13,500
| -51% | -$156K |
|
1824
Yext
YEXT
$501M
| $171K | ﹤0.01% |
14,234
-14,584
| -51% | -$188K |
|
|
EPZM
1825
DELISTED
Epizyme, Inc
EPZM
| $171K | ﹤0.01% |
33,348
-8,268
| -20% | -$50.2K |
|
Similar funds
ProShare Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, ProShare Advisors held 2,407 positions worth $35.6B, up 4% from $34.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
ProShare Advisors deployed $1.82B of net new capital in Q3 2021, opening 40 new positions and adding to 606 existing holdings. Its largest new stake was Sea Limited: 95,823 shares worth $30.5M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Stamps.com, Inc., an estimated $42.3M trimmed.
- ProShare Advisors's largest Q3 2021 buy was Sea Limited: 95,823 shares worth $30.5M.
- ProShare Advisors added most to Apple in Q3 2021, an estimated $172M increase.
- ProShare Advisors's biggest Q3 2021 reduction was Stamps.com, Inc., cutting an estimated $42.3M.
- ProShare Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $53.3M.
- ProShare Advisors's ten largest holdings make up 28% of its $35.6B portfolio in Q3 2021.
- ProShare Advisors opened 40 new positions and closed 406 in Q3 2021.
- ProShare Advisors's portfolio value rose 4% quarter-over-quarter to $35.6B.
Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.